pyridostigmine bromide has been researched along with Spinal Muscular Atrophies of Childhood in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asselman, FL; Bartels, B; Cuppen, I; de Groot, JF; Goedee, HS; Habets, LE; Otto, LAM; Schoenmakers, MAGC; Stam, M; van den Berg, LH; van der Pol, WL; Wadman, RI; Wijngaarde, CA | 1 |
| van den Berg, LH; van der Pol, WL; Vrancken, AF; Wadman, RI | 1 |
1 trial(s) available for pyridostigmine bromide and Spinal Muscular Atrophies of Childhood
| Article | Year |
|---|---|
Protocol for a phase II, monocentre, double-blind, placebo-controlled, cross-over trial to assess efficacy of pyridostigmine in patients with spinal muscular atrophy types 2-4 (SPACE trial).
Topics: Activities of Daily Living; Adolescent; Adult; Child; Child, Preschool; Cholinesterase Inhibitors; Clinical Trials, Phase II as Topic; Cross-Over Studies; Double-Blind Method; Drug Administration Schedule; Fatigue; Female; Humans; Infant; Male; Netherlands; Pyridostigmine Bromide; Quality of Life; Randomized Controlled Trials as Topic; Severity of Illness Index; Spinal Muscular Atrophies of Childhood; Treatment Outcome; Walk Test; Young Adult | 2018 |
1 other study(ies) available for pyridostigmine bromide and Spinal Muscular Atrophies of Childhood
| Article | Year |
|---|---|
Dysfunction of the neuromuscular junction in spinal muscular atrophy types 2 and 3.
Topics: Adolescent; Adult; Aged; Case-Control Studies; Chi-Square Distribution; Child; Cholinesterase Inhibitors; Electric Stimulation; Electromyography; Evoked Potentials, Motor; Female; Humans; Male; Middle Aged; Motor Neuron Disease; Muscular Atrophy, Spinal; Neuromuscular Junction Diseases; Pyridostigmine Bromide; Spinal Muscular Atrophies of Childhood; Young Adult | 2012 |